Suchergebnisse - "Sandin, Rickard"

PubPharm (52)

1

Emerging racial disparities among Medicare beneficiaries and Veterans with metastatic castration-sensitive prostate cancer

enthalten in: Prostate cancer and prostatic diseases | 2024

von George, D. | Agarwal, N. | Ramaswamy, K. | +11

2

Budget impact of oral nirmatrelvir/ritonavir in adults at high risk for progression to severe COVID-19 in the United States

enthalten in: Journal of managed care & specialty pharmacy | 2023

von Sandin, R. | Veenstra, D. | Vankelegom, M. | +8

3

Plain language summary : Does the amount of time it takes for prostate-specific antigen to double affect how long men with nonmetastatic castration-resistant prostate cancer live and their healthcare costs?

enthalten in: Future oncology (London, England) | 2023

von Freedland, S. | Ramaswamy, K. | Huang, A. | +4

4

Survival and Economic Impact of Rapid Prostate-Specific Antigen Doubling Time in Patients With Nonmetastatic Castration-Resistant Prostate Cancer

enthalten in: Clinical genitourinary cancer | 2023

von Freedland, S. | Ramaswamy, K. | Huang, A. | +5

5

The Role of Physician Specialty in the Underutilization of Standard-of-Care Treatment Intensification in Patients With Metastatic Castration-sensitive Prostate Cancer

enthalten in: The Journal of urology | 2023

von Swami, U. | Hong, A. | El-Chaar, N. | +6

CommentIn: J Urol. 2023 Jun;209(6):1130. - PMID 36950912

6

Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints in Cancer Clinical Trials-Innovative Medicines Initiative (SISAQOL-IMI) : stakeholder views, objectives, and procedures

enthalten in: The Lancet. Oncology | 2023

von Pe, M. | Alanya, A. | Falk, R. | +125

7

Single-arm studies involving patient-reported outcome data in oncology : a literature review on current practice

enthalten in: The Lancet. Oncology | 2023

von Liu, L. | Choi, J. | Musoro, J. | +54

8

Estimated Impact of Oral Nirmatrelvir;Ritonavir on Reductions in Hospitalizations and Associated Costs within High-Risk COVID-19 Patients in the US

enthalten in: ResearchSquare.com | 2023

von Sandin, R. | Harrison, C. | Draica, F. | +5

9

The cost impact of disease progression to metastatic castration-sensitive prostate cancer

enthalten in: Journal of managed care & specialty pharmacy | 2022

von Trinh, Q. | Chaves, L. | Feng, Q. | +3

10

Correction to : Survival outcomes in patients with chemotherapy-naive metastatic castration-resistant prostate cancer treated with enzalutamide or abiraterone acetate

enthalten in: Prostate cancer and prostatic diseases | 2022

von Tagawa, S. | Ramaswamy, K. | Huang, A. | +6

ErratumFor: Prostate Cancer Prostatic Dis. 2021 Dec;24(4):1032-1040. - PMID 33612825

1
2
3
4
5
6
Nächster »
[6]